Literature DB >> 28584056

Structural analyses of von Willebrand factor C domains of collagen 2A and CCN3 reveal an alternative mode of binding to bone morphogenetic protein-2.

Emma-Ruoqi Xu1, Emily E Blythe1, Gerhard Fischer1, Marko Hyvönen2.   

Abstract

Bone morphogenetic proteins (BMPs) are secreted growth factors that promote differentiation processes in embryogenesis and tissue development. Regulation of BMP signaling involves binding to a variety of extracellular proteins, among which are many von Willebrand factor C (vWC) domain-containing proteins. Although the crystal structure of the complex of crossveinless-2 (CV-2) vWC1 and BMP-2 previously revealed one mode of the vWC/BMP-binding mechanism, other vWC domains may bind to BMP differently. Here, using X-ray crystallography, we present for the first time structures of the vWC domains of two proteins thought to interact with BMP-2: collagen IIA and matricellular protein CCN3. We found that these two vWC domains share a similar N-terminal fold that differs greatly from that in CV-2 vWC, which comprises its BMP-2-binding site. We analyzed the ability of these vWC domains to directly bind to BMP-2 and detected an interaction only between the collagen IIa vWC and BMP-2. Guided by the collagen IIa vWC domain crystal structure and conservation of surface residues among orthologous domains, we mapped the BMP-binding epitope on the subdomain 1 of the vWC domain. This binding site is different from that previously observed in the complex between CV-2 vWC and BMP-2, revealing an alternative mode of interaction between vWC domains and BMPs.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  CCN proteins; bone morphogenetic protein (BMP); collagen; crystal structure; extracellular matrix protein; protein-protein interaction; signaling; vWC domain

Mesh:

Substances:

Year:  2017        PMID: 28584056      PMCID: PMC5535026          DOI: 10.1074/jbc.M117.788992

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  63 in total

1.  Antiproliferative activity of CCN3: involvement of the C-terminal module and post-translational regulation.

Authors:  A M Bleau; N Planque; N Lazar; D Zambelli; A Ori; T Quan; G Fisher; K Scotlandi; B Perbal
Journal:  J Cell Biochem       Date:  2007-08-15       Impact factor: 4.429

2.  Association of the metastatic phenotype with CCN family members among breast and oral cancer cells.

Authors:  Toshihiro Ohgawara; Satoshi Kubota; Harumi Kawaki; Naito Kurio; Tarek Abd El Kader; Mitsuhiro Hoshijima; Danilo Janune; Tsuyoshi Shimo; Bernard Perbal; Akira Sasaki; Masaharu Takigawa
Journal:  J Cell Commun Signal       Date:  2011-04-18       Impact factor: 5.782

3.  T7 vectors with modified T7lac promoter for expression of proteins in Escherichia coli.

Authors:  J Peränen; M Rikkonen; M Hyvönen; L Kääriäinen
Journal:  Anal Biochem       Date:  1996-05-01       Impact factor: 3.365

4.  Anti-fibrotic effect of CCN3 accompanied by altered gene expression profile of the CCN family.

Authors:  Tarek Abd El Kader; Satoshi Kubota; Danilo Janune; Takashi Nishida; Takako Hattori; Eriko Aoyama; Bernard Perbal; Takuo Kuboki; Masaharu Takigawa
Journal:  J Cell Commun Signal       Date:  2012-10-14       Impact factor: 5.782

5.  Solution structure of a pair of fibronectin type 1 modules with fibrin binding activity.

Authors:  M J Williams; I Phan; T S Harvey; A Rostagno; L I Gold; I D Campbell
Journal:  J Mol Biol       Date:  1994-01-28       Impact factor: 5.469

6.  Novel effects of CCN3 that may direct the differentiation of chondrocytes.

Authors:  Danilo Janune; Satoshi Kubota; Takashi Nishida; Harumi Kawaki; Bernard Perbal; Seiji Iida; Masaharu Takigawa
Journal:  FEBS Lett       Date:  2011-08-23       Impact factor: 4.124

7.  Crystal structure analysis reveals how the Chordin family member crossveinless 2 blocks BMP-2 receptor binding.

Authors:  Jin-Li Zhang; Li-Yan Qiu; Alexander Kotzsch; Stella Weidauer; Lucy Patterson; Matthias Hammerschmidt; Walter Sebald; Thomas D Mueller
Journal:  Dev Cell       Date:  2008-05       Impact factor: 12.270

8.  CCN3 (NOV) is a novel angiogenic regulator of the CCN protein family.

Authors:  Cristiane G Lin; Shr-Jeng Leu; Ningyu Chen; Christopher M Tebeau; Shao-Xia Lin; Cho-Yau Yeung; Lester F Lau
Journal:  J Biol Chem       Date:  2003-04-13       Impact factor: 5.157

9.  CTGF inhibits BMP-7 signaling in diabetic nephropathy.

Authors:  Tri Q Nguyen; Peggy Roestenberg; Frans A van Nieuwenhoven; Niels Bovenschen; Zeke Li; Leon Xu; Noelynn Oliver; Jan Aten; Jaap A Joles; Cecilia Vial; Enrique Brandan; Karen M Lyons; Roel Goldschmeding
Journal:  J Am Soc Nephrol       Date:  2008-07-16       Impact factor: 10.121

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  11 in total

1.  Connective tissue growth factor (CCN2) is a matricellular preproprotein controlled by proteolytic activation.

Authors:  Ole Jørgen Kaasbøll; Ashish K Gadicherla; Jian-Hua Wang; Vivi Talstad Monsen; Else Marie Valbjørn Hagelin; Meng-Qiu Dong; Håvard Attramadal
Journal:  J Biol Chem       Date:  2018-09-27       Impact factor: 5.157

Review 2.  The concept of the CCN protein family revisited: a centralized coordination network.

Authors:  Bernard Perbal
Journal:  J Cell Commun Signal       Date:  2018-02-22       Impact factor: 5.782

3.  Structural biology of the TGFβ family.

Authors:  Erich J Goebel; Kaitlin N Hart; Jason C McCoy; Thomas B Thompson
Journal:  Exp Biol Med (Maywood)       Date:  2019-10-09

Review 4.  Acquired Von Willebrand Syndrome (AVWS) in cardiovascular disease: a state of the art review for clinicians.

Authors:  Radha Mehta; Muhammad Athar; Sameh Girgis; Atif Hassan; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2019-07       Impact factor: 2.300

5.  Modelling the structure of Short Gastrulation and generation of a toolkit for studying its function in Drosophila.

Authors:  Sophie L Frampton; Catherine Sutcliffe; Clair Baldock; Hilary L Ashe
Journal:  Biol Open       Date:  2022-06-10       Impact factor: 2.643

6.  Structure and dynamics of the platelet integrin-binding C4 domain of von Willebrand factor.

Authors:  Emma-Ruoqi Xu; Sören von Bülow; Po-Chia Chen; Peter J Lenting; Katra Kolšek; Camilo Aponte-Santamaría; Bernd Simon; Jaelle Foot; Tobias Obser; Reinhard Schneppenheim; Frauke Gräter; Cécile V Denis; Matthias Wilmanns; Janosch Hennig
Journal:  Blood       Date:  2018-10-10       Impact factor: 22.113

7.  lncRNA HAR1B has potential to be a predictive marker for pazopanib therapy in patients with sarcoma.

Authors:  Hideharu Yamada; Masanobu Takahashi; Munenori Watanuki; Mika Watanabe; Sakura Hiraide; Ken Saijo; Keigo Komine; Chikashi Ishioka
Journal:  Oncol Lett       Date:  2021-04-08       Impact factor: 2.967

Review 8.  Connective Tissue Growth Factor: From Molecular Understandings to Drug Discovery.

Authors:  Zihao Chen; Ning Zhang; Hang Yin Chu; Yuanyuan Yu; Zong-Kang Zhang; Ge Zhang; Bao-Ting Zhang
Journal:  Front Cell Dev Biol       Date:  2020-10-29

Review 9.  Collagen Biosynthesis, Processing, and Maturation in Lung Ageing.

Authors:  Ceylan Onursal; Elisabeth Dick; Ilias Angelidis; Herbert B Schiller; Claudia A Staab-Weijnitz
Journal:  Front Med (Lausanne)       Date:  2021-05-20

Review 10.  SCO-spondin, a giant matricellular protein that regulates cerebrospinal fluid activity.

Authors:  Vania Sepúlveda; Felipe Maurelia; Maryori González; Jaime Aguayo; Teresa Caprile
Journal:  Fluids Barriers CNS       Date:  2021-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.